Wealth Enhancement Advisory Services »

Urogen Pharma shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $295k 7.6k 38.56

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
NVIDIA Corporation (NVDA)
Alps Etf Tr Smith Core Plus (SMTH)
Microsoft Corporation Put Option (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Fundamental Intl (FNDF)
Victory Portfolios Ii Usaa Msci Usa Sm (USVM)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Msci Intl Moment (IMTM)
Micron Technology (MU)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Urogen Pharma

Rtw Investments
BlackRock
Morgan Stanley
Kynam Capital Management
Leucadia National Corporation
SG Americas Securities
American Century Companies
Acorn Capital Advisors
Point72 Asset Management
Frontier Capital Management
Opaleye Management
Silverarc Capital Management
Menora Mivtachim Holdings
D. E. Shaw & Co
MPM Oncology Impact Management

View all funds holding Urogen Pharma